We are live on ! Find out more
HA

Homestead Advisers Portfolio holdings

AUM $3.72B
1-Year Est. Return 24.04%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+24.04%
3 Year Est. Return
+73.21%
5 Year Est. Return
+100.2%
10 Year Est. Return
+356.14%
AUM
$3.91B
AUM Growth
+$312M
Cap. Flow
-$66.7M
Cap. Flow %
-1.7%
Top 10 Hldgs %
30.99%
Holding
137
New
6
Increased
51
Reduced
24
Closed
3

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$31.4M
2
LKQ icon
LKQ Corp
LKQ
+$20.1M
3
CCI icon
Crown Castle
CCI
+$19.6M
4
PHM icon
Pultegroup
PHM
+$16.8M
5
DIS icon
Walt Disney
DIS
+$7.33M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$25.1M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$21M
3
MSFT icon
Microsoft
MSFT
+$19.6M
4
META icon
Meta Platforms (Facebook)
META
+$18M
5
FCX icon
Freeport-McMoran
FCX
+$17.5M

Sector Composition

Rank Sector Weight
1 Financials 18.38%
2 Healthcare 17.73%
3 Industrials 17.41%
4 Technology 11.32%
5 Consumer Discretionary 10.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PH icon
1
Parker-Hannifin
PH
$125B
$154M 3.94%
334,980
-41,400
-11% -$17.2M
JPM icon
2
JPMorgan Chase
JPM
$939B
$153M 3.91%
899,136
-56,200
-6% -$8.52M
HON icon
3
Honeywell
HON
$77.1B
$134M 3.43%
679,258
+1,274
+0.2% +$230K
META icon
4
Meta Platforms (Facebook)
META
$1.51T
$116M 2.96%
327,800
-55,300
-14% -$18M
GS icon
5
Goldman Sachs
GS
$313B
$113M 2.9%
294,036
+500
+0.2% +$167K
ABT icon
6
Abbott
ABT
$180B
$112M 2.86%
1,015,246
-85,900
-8% -$8.58M
ABBV icon
7
AbbVie
ABBV
$458B
$108M 2.77%
699,560
-45,800
-6% -$6.68M
CB icon
8
Chubb
CB
$140B
$108M 2.76%
477,677
+1,100
+0.2% +$241K
GOOG icon
9
Alphabet (Google) Class C
GOOG
$3.9T
$107M 2.74%
760,460
-155,000
-17% -$21M
COP icon
10
ConocoPhillips
COP
$147B
$107M 2.73%
919,181
+1,842
+0.2% +$215K
MSFT icon
11
Microsoft
MSFT
$2.84T
$104M 2.67%
277,687
-55,000
-17% -$19.6M
FISV
12
Fiserv Inc
FISV
$27.2B
$103M 2.63%
774,300
+1,400
+0.2% +$172K
CVX icon
13
Chevron
CVX
$388B
$95.2M 2.43%
638,005
+1,393
+0.2% +$211K
BSX icon
14
Boston Scientific
BSX
$65.8B
$95M 2.43%
1,643,526
+2,900
+0.2% +$155K
CNC icon
15
Centene
CNC
$31.3B
$92.9M 2.37%
1,251,325
+2,200
+0.2% +$159K
AVY icon
16
Avery Dennison
AVY
$12.3B
$90.6M 2.32%
448,358
+800
+0.2% +$149K
V icon
17
Visa
V
$677B
$88M 2.25%
337,874
-54,600
-14% -$13.5M
LRCX icon
18
Lam Research
LRCX
$382B
$86.9M 2.22%
1,110,000
+67,000
+6% +$4.57M
NOC icon
19
Northrop Grumman
NOC
$77B
$85M 2.17%
181,572
+300
+0.2% +$141K
NXPI icon
20
NXP Semiconductors
NXPI
$68B
$83.5M 2.13%
363,503
+600
+0.2% +$121K
CSX icon
21
CSX Corp
CSX
$98.6B
$83.3M 2.13%
2,404,036
+4,500
+0.2% +$143K
ETN icon
22
Eaton
ETN
$157B
$82.7M 2.11%
343,304
+700
+0.2% +$155K
HES
23
DELISTED
Hess
HES
$79M 2.02%
548,300
+1,000
+0.2% +$147K
DE icon
24
Deere & Co
DE
$170B
$73.5M 1.88%
183,722
+300
+0.2% +$113K
CI icon
25
Cigna
CI
$76.6B
$72.8M 1.86%
243,162
+400
+0.2% +$117K
1
2 3 4 5

Similar funds

OIMU
Osmosis Investment Management UK London, United Kingdom $3.72B AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
OCBCO
Oversea-Chinese Banking Corp (OCBC) Singapore $3.7B AUM 28.52% 1-Year Est. Return
SAI
Savvy Advisors Inc New York $3.75B AUM 21.95% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Homestead Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, Homestead Advisers held 137 positions worth $3.91B, up 8.7% from $3.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Homestead Advisers's Q4 2023 filing shows 6 new, 51 increased, 24 reduced and 3 closed positions. Its largest new stake was Oracle: 287,700 shares worth $30.3M. The largest sale was Pfizer, an estimated $25.1M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

  • Homestead Advisers's largest Q4 2023 buy was Oracle: 287,700 shares worth $30.3M.
  • Homestead Advisers added most to Crown Castle in Q4 2023, an estimated $19.6M increase.
  • Homestead Advisers's biggest Q4 2023 reduction was Pfizer, cutting an estimated $25.1M.
  • Homestead Advisers fully exited Ziff Davis in Q4 2023, selling an estimated $4M.
  • Homestead Advisers's ten largest holdings make up 31% of its $3.91B portfolio in Q4 2023.
  • Homestead Advisers opened 6 new positions and closed 3 in Q4 2023.
  • Homestead Advisers's portfolio value rose 8.7% quarter-over-quarter to $3.91B.

Based on Homestead Advisers's 13F filing for Q4 2023, filed 13 Feb 2024.